PURPOSE: To review the current literature on the detection and measurement of antiretinal antibodies. DESIGN: Collaborative essay. METHODS: Literature review and interpretation. RESULTS: There is strong evidence to suggest a role for antiretinal antibodies, particularly those targeting recoverin and alpha-enolase, in the pathogenesis of autoimmune retinopathy (AIR). Additionally, numerous other autoantibodies have been described as putative mediators of retinal degeneration and more remain to be discovered. However, assay methods described in the literature by many laboratories for the detection of circulating antiretinal antibodies have been varied and diverse, making it difficult to interpret and compare their results. CONCLUSIONS: There is currently little standardization of laboratory methods used to detect and monitor antiretinal antibodies. To measure and monitor levels of circulating antiretinal antibodies optimally in patients with AIR, development of standardized assays with stringent internal controls is required. A multicenter collaborative and validation effort is encouraged to reach a consensus on this issue.
PURPOSE: To review the current literature on the detection and measurement of antiretinal antibodies. DESIGN: Collaborative essay. METHODS: Literature review and interpretation. RESULTS: There is strong evidence to suggest a role for antiretinal antibodies, particularly those targeting recoverin and alpha-enolase, in the pathogenesis of autoimmune retinopathy (AIR). Additionally, numerous other autoantibodies have been described as putative mediators of retinal degeneration and more remain to be discovered. However, assay methods described in the literature by many laboratories for the detection of circulating antiretinal antibodies have been varied and diverse, making it difficult to interpret and compare their results. CONCLUSIONS: There is currently little standardization of laboratory methods used to detect and monitor antiretinal antibodies. To measure and monitor levels of circulating antiretinal antibodies optimally in patients with AIR, development of standardized assays with stringent internal controls is required. A multicenter collaborative and validation effort is encouraged to reach a consensus on this issue.
Authors: T Maeda; A Maeda; I Maruyama; K I Ogawa ; Y Kuroki; H Sahara; N Sato; H Ohguro Journal: Invest Ophthalmol Vis Sci Date: 2001-03 Impact factor: 4.799
Authors: Michael J Potter; Grazyna Adamus; Shelagh M Szabo; Rehwa Lee; Kam Mohaseb; Darren Behn Journal: Am J Ophthalmol Date: 2002-07 Impact factor: 5.258
Authors: Marianna Mkrtchyan; Brandon J Lujan; David Merino; Charles E Thirkill; Austin Roorda; Jacque L Duncan Journal: Am J Ophthalmol Date: 2011-11-20 Impact factor: 5.258
Authors: Austin R Fox; Lynn K Gordon; John R Heckenlively; Janet L Davis; Debra A Goldstein; Careen Y Lowder; Robert B Nussenblatt; Nicholas J Butler; Monica Dalal; Thiran Jayasundera; Wendy M Smith; Richard W Lee; Grazyna Adamus; Chi-Chao Chan; John J Hooks; Catherine W Morgans; Barbara Detrick; H Nida Sen Journal: Am J Ophthalmol Date: 2016-05-20 Impact factor: 5.258
Authors: Josianne C Ten Berge; Joost van Rosmalen; Jacolien Vermeer; Cecilia Hellström; Cecilia Lindskog; Peter Nilsson; Ulrika Qundos; Aniki Rothova; Marco W J Schreurs Journal: PLoS One Date: 2016-12-08 Impact factor: 3.240